7 completed, 2 not yet recruiting, 2 recruiting, 1 active not recruiting. 5 Phase 2, 3 Not applicable, 3 Phase 1, 2 Phase 4, 1 Phase 3.
Follow Primary Open-Angle Glaucoma (POAG): new trials by email Literature Review of Primary Open-Angle Glaucoma (POAG) trials Research Report on Primary Open-Angle Glaucoma (POAG)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dorzolamide/Brimonidine/Timolol Impact on Ocular Surface, Glaucoma Progression & Chatbot Follow-up: GLAUCO-TECH Preservative-free dorzolamide-timolol-brimonidine combination, Preservative dorzolamide-timolol-brimonidine combination - Primary Open-Angle Glaucoma (POAG), Ocular Hypertension | Phase 4 | Active not recruiting | Tecnoquimicas | 140 | 2026-06-10 | 2026-07-08 |
| Personalized Mobile Reminders for Medication Adherence and Intraocular Pressure Control in Primary Open-Angle Glaucoma Digital Reminder Intervention - Primary Open-Angle Glaucoma (POAG) | Not applicable | Not yet recruiting | Sakarya Yenikent State Hospital | 84 | 2026-04-01 | 2026-03-18 |
| Aqueous Humor and Ocular Tissue Analysis in Glaucoma and Cataract Phacoemulsification With Intraocular Lens Implantation and Deep Sclerectomy, Phacoemulsification With Intraocular Lens Implantation - Primary Open-Angle Glaucoma (POAG), Cataract | Not applicable | Recruiting | Military Institute od Medicine National Research Institute | 40 | 2026-01-21 | 2026-03-10 |
| GVB-2001 Gene Therapy Via Intracameral Injection for the Treatment of Primary Open Angle Glaucoma GVB-2001-high dose, GVB-2001-low dose - Primary Open-Angle Glaucoma (POAG) | Phase 1 / Phase 2 | Recruiting | IVIEW Therapeutics Inc. | 6 | 2025-11-19 | 2026-05-04 |
| Effect of Niacinamide Supplementation in Glaucoma niacinamide supplementation - Primary Open-Angle Glaucoma (POAG) | Not applicable | Completed | University of Medicine and Pharmacy Craiova | 58 | 2024-02-20 | 2025-07-17 |
| MEXIDOL® Sequential Therapy of Patients With Primary Open-angle Glaucoma (POAG) Mexidol - Primary Open-Angle Glaucoma (POAG) | Phase 4 | Completed | Pharmasoft | 80 | 2023-09-15 | 2025-12-12 |
| Role of Peripheral Vision in Scene Perception (PERISCE) Psychophysical evaluation - Primary Open-angle Glaucoma (POAG) | Not yet recruiting | University Hospital, Grenoble | 120 | 2022-10-01 | 2022-09-14 | |
| Efficacy and Safety of Different Dosages of Mexidol® in Patients With Primary Open-angle Glaucoma (POAG) Mexidol, Placebo - Primary Open-Angle Glaucoma (POAG) | Phase 2 | Completed | Pharmasoft | 102 | 2021-11-15 | 2025-12-12 |
| Study of SHP639 Eye Drops in Adults With High Eye Pressure or Primary Open-angle Glaucoma SHP639 (n=60), Placebo Comparator (n=24) - Primary Open-angle Glaucoma (POAG), Ocular Hypertension | Phase 1 | Completed | Shire | 63 | 2017-05-10 | 2021-06-08 |
| Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAG trabodenoson 6.0% / latanoprost 0.005% QD, trabodenoson 3.0% / latanoprost 0.005% QD, trabodenoson 6.0% / latanoprost 0.0025% QD - Primary Open-Angle Glaucoma (POAG), Ocular Hypertension (OHT) | Phase 2 | Completed | Inotek Pharmaceuticals Corporation | 201 | 2016-08-19 | 2018-02-15 |
| Study of Trabodenoson in Adults With Ocular Hypertension or Primary Open-angle Glaucoma trabodenoson 4.5% BID, trabodenoson 6.0% QD, trabodenoson 3.0% QD - Primary Open-Angle Glaucoma (POAG), Ocular Hypertension (OHT) | Phase 3 | Completed | Inotek Pharmaceuticals Corporation | 303 | 2015-09-01 | 2016-12-06 |
| Safety and Efficacy of Deep Wave Trabeculoplasty (DWT) in Primary Open Angle Glaucoma and Ocular Hypertension DWT device dose A, Ellex Tango SLT machine, DWT device dose B - Primary Open-angle Glaucoma (POAG), Ocular Hypertension (OHT) | Phase 1 / Phase 2 | Terminated | OcuTherix, Inc. | 35 | 2013-11-01 | 2017-04-04 |
| A Phase II Study to Evaluate the Additivity of Trabodenoson to Latanoprost in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma Trabodenoson, Latanoprost, Timolol - Primary Open-Angle Glaucoma (POAG), Ocular Hypertension (OHT) | Phase 2 | Completed | Inotek Pharmaceuticals Corporation | 101 | 2013-08-01 | 2017-12-02 |
Glaucoma, Open-Angle (13) · Glaucoma (8) · Ocular Hypertension (6) · Mitochondrial Diseases (2) · Cataract (1) · Medication Adherence (1) · Night Blindness, Congenital Stationary, Autosomal Dominant 1 (1)
Eye Diseases (13) · Ocular Hypertension (7) · Glaucoma (5) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2) · Behavior (1) · Health Behavior (1) · Lens Diseases (1) · Patient Acceptance of Health Care (1) · Patient Compliance (1) · Treatment Adherence and Compliance (1)
trabodenoson (3) · INO-8875 (2) · Latanoprost (2) · Timolol (2) · emoxypine succinate (2) · ethylmethylhydroxypyridine succinate (2) · BID protein, human (1) · Biomarkers (1) · Lens Implantation, Intraocular (1) · Phacoemulsification (1)
Inotek Pharmaceuticals Corporation (3) · Pharmasoft (2) · IVIEW Therapeutics Inc. (1) · Military Institute od Medicine National Research Institute (1) · OcuTherix, Inc. (1) · Sakarya Yenikent State Hospital (1) · Shire (1) · Tecnoquimicas (1) · University Hospital, Grenoble (1) · University of Medicine and Pharmacy Craiova (1)
United States (4) · Russia (2) · China (1) · Colombia (1) · Philippines (1) · Poland (1) · Romania (1)
Cadmus C Rich, MD,MBA,CPE (2) · Carlos Cifuentes, MD (1) · Edgar U. Leuenberger, MD (1) · Ewa Bulska, PhD (1) · Harvey Siy Uy, MD (1) · Maria I Yap-Veloso, MD (1) · Peirong Lu, MD (1)